Cargando…
Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
BACKGROUND: Attempts to characterize cardiac structure in heart failure with preserved ejection fraction (HFpEF) in people with type 2 diabetes (T2D) have yielded inconsistent findings. We aimed to determine whether patients with HFpEF and T2D have a distinct pattern of cardiac remodelling compared...
Autores principales: | Gulsin, Gaurav S., Kanagala, Prathap, Chan, Daniel C. S., Cheng, Adrian S. H., Athithan, Lavanya, Graham-Brown, Matthew P. M., Singh, Anvesha, Yang, Jing, Li, Zhuyin, Khunti, Kamlesh, Davies, Melanie J., Arnold, Jayanth R., Squire, Iain B., Ng, Leong L., McCann, Gerry P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613057/ https://www.ncbi.nlm.nih.gov/pubmed/31308926 http://dx.doi.org/10.1177/2042018819861593 |
Ejemplares similares
-
Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2020) -
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019) -
Plasma P‐selectin is a predictor of mortality in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2021) -
Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2020) -
Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes
por: Kanagala, Prathap, et al.
Publicado: (2020)